Authors: Gu Zhongxiu, Jiang Jing, Huang Min, Wu Mianmian, Guo Fang, Li Shenjun, Fang Jianmin, Zhao Shaozhen, Zhang Yan DOI: 10.3760/cma.j.issn.2095-0160.2018.08.002 Published 2018-08-10 Cite as Chin J Exp Ophthalmol, 2018,36(8): 581-589. Abstract [Download PDF] [Read Full Text] Objective To compare the pharmacodynamics between different batches of recombinant decoy receptor innovative drug RC28-E1 and RC28-E2 […]
Tag: Vascular endothelial growth factor
Treatment of wet age-related macular degeneration: Now and future
Authors: Ding Xiaoyan, Wang Zhirong, Sun Limei DOI: 10.3760/cma.j.issn.2095-0160.2019.01.014 Published 2019-01-10 Cite as Chin J Exp Ophthalmol, 2019,37(1): 63-68. Abstract [Download PDF] [Read Full Text] Wet age-related macular degeneration (AMD), which is the leading cause of visual impairment in elderly people, significantly affects quality of life of millions […]
Problems and challenges of anti-vascular endothelial growth factor therapy for ocular neovescularization diseases
Authors: Chen Youxin, Tang Jia DOI: 10.3760/cma.j.issn.2095-0160.2019.01.001 Published 2019-01-10 Cite as Chin J Exp Ophthalmol, 2019,37(1): 1-4. Abstract [Download PDF] [Read Full Text] Anti-vascular endothelial growth factor (VEGF) therapy is a major strategy for treating ocular neovascular diseases nowadays.It has revolutionarily improved the […]
Inhibitory effect of Tanshinone ⅡA on the proliferation of human retinal pigment epithelial cells in hypoxia and its mechanism
Authors: Lei Xiang, Li Zhanrong, Fan Ke DOI: 10.3760/cma.j.issn.2095-0160.2019.05.005 Published 2019-05-10 Cite as Chin J Exp Ophthalmol, 2019,37(5): 342-347. Abstract [View PDF] [Read Full text] Objective To investigate the effect of Tanshinone ⅡA on the proliferation and the signaling pathway of human retinal pigment epithelial […]